Unijules Life Sciences Ltd manufactures and markets allopathic, herbal, and nutraceutical formulations — aiming to make high-quality healthcare affordable for the common man. If you or someone you know has experienced a suspected side effect from one of our products, please tell us about it below.
We believe pharmaceutical innovation should reach the common man at an affordable cost, not just the affluent. Our teams work across allopathic, herbal, and nutraceutical formulation, pairing research and development with WHO-GMP certified manufacturing, so that new drug delivery advances reach the market faster and more reliably.
A dedicated R&D wing, including proprietary pellet-based herbal delivery technology and ongoing formulation development.
Expertise spanning capsules, tablets, injectables, liquids, semisolids and powders across allopathic and herbal product lines.
WHO-GMP certified facilities with an in-house quality-control and microbiology laboratory, staffed by experienced QA technocrats.
Critical care, anti-infective, gastrointestinal, anti-allergic and cough preparations.
Ayurvedic and herbal formulations, including our pellet-based Herbules delivery technology.
Nutritional and dietary supplement formulations for everyday health support.
Diagnostic imaging contrast agents for radiology use.
Sterile large-volume infusion products for hospital and institutional use.
Sterile injectable formulations in small-volume presentations.
Directly-compressible bulk granules supplied for further pharmaceutical manufacture.
Unijules maintains a dedicated Drug Safety Cell to receive, review, and investigate reports of suspected adverse reactions to our products — including a cell specifically covering our injectable product line. Every report submitted here is reviewed by our safety team; serious reports are prioritized and followed up according to regulatory timelines.
Report an Adverse Event Now